Santen Acquires Eyevance Shares in Agreement

New York resident and investor, Roger Coleman, owns Coleman Ventures & Coleman Group Partners-based in New York City. As proprietor, Roger Coleman is involved in impacting investing, committing some of the company's returns to his charitable foundation for positive outcomes around the world.

In September 2020, Mr. Coleman helped facilitate a deal between Santen Pharmaceutical Company, Ltd. (Santen) and Eyevance Holdings, LLC (Eyevance) that culminated in the former purchasing all outstanding shares of the latter. Santen is an ophthalmological company specializing in pharmaceuticals and medical devices. Eyevance makes topical products for the eyes.

Currently, Santen is the market leader in Japan and patients in 60 other countries use its products. This purchase will allow the company to establish a larger business base in the US while offering patients more value. By gaining access to the US market, they hope to facilitate corporate growth and the ability to contribute to making ophthalmic treatments worldwide.